Antinuclear Antibodies (Titre & Pattern)
Private ANA testing in London for £88, reporting one autoimmune marker with titre and pattern and results expected in around 5 days.
Turnaround time
5 business days
Biomarkers count
1
Book your test
Choose Service Type
Professional phlebotomist comes to you
+ £{{ home_visit_fee }}
Visit our clinic for your test
{{ clinic_visit_fee > 0 ? '+ £' + clinic_visit_fee : 'Free' }}
Home Visit Details
Home visits require at least 24 hours notice.
Select a clinic: Sorting by distance…
{{ clinicAddress(clinic) }}
{{ clinicAddress(selectedClinic) }}
Select a date
Select an hour
Available time slots: {{ timeSlots.length}}
Overview of the Antinuclear Antibodies (Titre & Pattern) Test
The Antinuclear Antibodies (Titre & Pattern) blood test detects autoantibodies directed against structures within the nucleus of the body's cells.
The test assesses 1 specialist autoimmune marker: Antinuclear Antibodies (titre & pattern).
Antinuclear Antibodies, commonly abbreviated to ANA, are among the most widely used laboratory markers when systemic autoimmune or connective tissue disease is being investigated.
The immune system normally produces antibodies to recognise foreign targets.
In autoimmune disease, antibodies can instead react against components of the body's own tissues.
ANA testing is particularly associated with conditions such as systemic lupus erythematosus, Sjögren's syndrome, systemic sclerosis and mixed connective tissue disease.
However, ANA is a screening marker rather than a diagnosis.
Low-level ANA can occur in otherwise healthy people, particularly with increasing age, and can also appear with infections, certain medicines and other autoimmune conditions.
This test provides both an ANA titre and staining pattern.
The titre reflects the dilution at which antinuclear antibody activity remains detectable.
The fluorescence pattern describes how antibodies bind to structures within the cell.
Examples can include homogeneous, speckled, nucleolar and centromere patterns.
Different patterns can provide clues about which more specific antibodies may be present, although a pattern cannot diagnose a particular autoimmune condition by itself.
Where ANA is positive and symptoms are compatible with connective tissue disease, further testing may include Extractable Nuclear Antibodies, Double-Stranded DNA antibodies, Complement levels and other targeted autoimmune markers.
The result should always be interpreted alongside symptoms, examination findings and the wider laboratory picture.
What Does the Antinuclear Antibodies (Titre & Pattern) Test Check?
The test detects Antinuclear Antibodies and reports the antibody titre and staining pattern to support investigation of systemic autoimmune and connective tissue conditions. This test measures 1 specialist biomarker.
Antinuclear Antibodies (titre & pattern)
Detects antibodies directed against nuclear structures and reports their titre and fluorescence pattern, supporting investigation of systemic autoimmune and connective tissue disease.
Who May Benefit From the Antinuclear Antibodies (Titre & Pattern) Test?
ANA testing can be useful where symptoms or other blood-test abnormalities raise suspicion of a systemic autoimmune or connective tissue disorder.
People with persistent unexplained joint pain or swelling - Connective tissue diseases can affect joints and may prompt ANA screening.
People with unexplained skin rashes or photosensitivity - Certain autoimmune conditions can produce skin symptoms that worsen after sun exposure.
People with persistent dry eyes or dry mouth - These symptoms can occur in Sjögren's syndrome and may prompt wider autoimmune investigation.
People with Raynaud's phenomenon - Colour changes in the fingers or toes triggered by cold can occur in systemic autoimmune conditions.
People with unexplained inflammatory symptoms affecting several systems - Multisystem symptoms can justify broad autoimmune screening.
People with a family history of connective tissue disease - Family history can provide additional context where compatible symptoms are present.
People with previous abnormal autoimmune results - ANA titre and pattern can provide further information where earlier testing was incomplete.
People advised to undergo connective tissue disease screening - ANA is commonly used as an initial laboratory investigation before more specific autoantibody tests.
How to Prepare
Do not stop prescribed medication simply to influence the ANA result.
ANA is most informative when the laboratory finding is interpreted alongside the person's symptoms and more specific autoimmune testing where appropriate.
Symptoms and Reasons to Consider the Antinuclear Antibodies (Titre & Pattern) Test
ANA testing is most useful when there is a compatible clinical reason for investigating systemic autoimmunity.
Persistent joint pain or swelling - Inflammatory joint symptoms can occur in several connective tissue diseases.
Photosensitive skin rashes - Rashes triggered or worsened by sunlight can occur in lupus and other autoimmune conditions.
Dry eyes or dry mouth - Persistent dryness can form part of Sjögren's syndrome.
Raynaud's phenomenon - Fingers or toes becoming white, blue or red in the cold can occur with connective tissue disease.
Unexplained mouth ulcers - Recurrent ulcers can occur in some systemic autoimmune disorders.
Persistent unexplained fatigue - Fatigue can accompany autoimmune disease but is highly non-specific.
Unexplained fever or systemic inflammation - Recurrent inflammatory symptoms can prompt broader autoimmune investigation.
Previous abnormal ANA or autoimmune testing - Repeat titre and pattern testing can provide additional context.
A positive ANA result does not automatically mean an autoimmune disease is present.
Low titres can occur in healthy people, and the clinical significance depends on the titre, pattern, symptoms and other laboratory findings.
A negative ANA reduces the likelihood of several connective tissue diseases but does not exclude every autoimmune condition.
How to Book Your Antinuclear Antibodies (Titre & Pattern) Test
The Antinuclear Antibodies (Titre & Pattern) test can be booked privately for specialist autoimmune and connective tissue disease screening.
Choose the Antinuclear Antibodies (Titre & Pattern)
Select the individual ANA titre and pattern blood test online.
Select your sample collection option
Choose an in-clinic blood draw or professional home or hotel phlebotomy where suitable.
Attend your appointment
A trained healthcare professional collects the required venous blood sample.
Laboratory analysis
Your serum undergoes specialist analysis for Antinuclear Antibodies (titre & pattern).
Receive your results securely
Your authorised result is delivered securely and can be interpreted alongside ENA, dsDNA and other autoimmune markers where appropriate.
When Will I Receive My Results?
The current London Blood Tests turnaround for Antinuclear Antibodies (Titre & Pattern) is approximately 5 days after laboratory receipt.
ANA titre and pattern testing requires specialist autoimmune analysis.
The sample undergoes laboratory testing, pattern assessment, quality-control procedures and result authorisation.
Turnaround begins when the specimen reaches the laboratory rather than necessarily from the exact time of collection.
Further ENA or disease-specific antibody testing can extend the overall investigation where additional testing is required.
Understanding Your Results
ANA results may include whether antibodies were detected, the titre and the staining pattern.
A negative result means significant ANA activity was not detected according to the laboratory method.
A positive result means Antinuclear Antibodies were detected.
The titre provides information about the concentration of detectable antibodies.
Lower titres can occur without autoimmune disease, while higher titres can become more clinically relevant when compatible symptoms are present.
The pattern can also provide useful clues.
A homogeneous pattern can occur with lupus and other conditions.
Speckled patterns can occur across several connective tissue disorders.
Nucleolar patterns may be associated with systemic sclerosis, while centromere patterns can occur in limited cutaneous systemic sclerosis.
These associations are not diagnostic.
More specific testing is often required.
Extractable Nuclear Antibodies and other targeted autoantibodies can help identify the particular autoimmune response responsible for a positive ANA.
Why Book With London Blood Tests?
London Blood Tests provides private access to ANA titre and pattern testing for detailed autoimmune investigation.
Reports both titre and pattern - The result provides more information than a simple positive or negative ANA screen.
Useful as a first-line autoimmune investigation - ANA is widely used where connective tissue disease is suspected.
Can guide targeted follow-up testing - The titre and pattern can help determine whether ENA, dsDNA or other antibodies should be investigated.
Relevant to multisystem symptoms - ANA can support investigation where joints, skin, glands or other organs may be involved.
Specialist laboratory analysis - Samples undergo dedicated autoimmune antibody testing.
Results in around 5 days - The current expected turnaround is approximately 5 days after laboratory receipt.
Professional blood collection - Clinic and suitable home or hotel phlebotomy appointments are available.
Clear pricing - The Antinuclear Antibodies (Titre & Pattern) test costs £88.
Private Antinuclear Antibodies (Titre & Pattern) Blood Test in London
London Blood Tests provides private Antinuclear Antibodies (Titre & Pattern) testing for people requiring specialist autoimmune screening.
The test costs £88 and assesses 1 specialist biomarker.
Results are expected approximately 5 days after laboratory receipt.
ANA should be interpreted alongside symptoms and more specific autoimmune markers rather than used alone to diagnose a connective tissue disease.